Enhancing MRNA Production Quality: Comprehensive Charge Detection Mass Spectrometry (CDMS) Analysis of DNA Plasmid and MRNA Structures

Importance of the Topic

The efficient production of high-quality mRNA is critical for therapeutic and vaccine development. Key to this process is the accurate characterization of DNA plasmid templates and resulting mRNA molecules. Conventional methods like capillary electrophoresis face challenges in resolving different plasmid topologies, potentially compromising yield and purity. Advanced analytical techniques such as Charge Detection Mass Spectrometry (CDMS) offer direct mass measurement of individual macromolecules, providing deeper insight into template integrity and its influence on downstream mRNA synthesis.

Study Aims and Overview

This work aims to apply CDMS with an electrostatic linear ion trap to characterize various DNA plasmid structures (supercoiled, open-circular, linear) and circular mRNA species. By comparing CDMS data with standard capillary electrophoresis, the study evaluates the technique’s accuracy in mass determination and its ability to detect degradation or structural variants affecting mRNA production quality.

Methodology and Instrumentation

Ultrapure samples of eGFP mRNA and plasmids pUC19, pBR322 were prepared by buffer exchange into ammonium acetate with Pluronic F-68 using size-exclusion columns. Capillary electrophoresis (Agilent 5200 Fragment Analyzer) provided length-based separation for comparison. CDMS analysis was performed on a prototype ELIT-based spectrometer in positive nanoelectrospray mode. Single ions were trapped for 100 ms; induced charge and oscillation frequency were recorded, yielding simultaneous mass-to-charge and charge measurements for direct mass calculation. Data processing included Fourier transform signal analysis and two-dimensional heat-map generation.

Key Results and Discussion

• CDMS accurately determined masses of intact circular pUC19 (1.75 MDa), pBR322 (2.83 MDa), and eGFP mRNA (0.54 MDa), with deviations below 2 % from theoretical values.
• Capillary electrophoresis showed acceptable deviation (~4 % for pUC19, ~7 % for pBR322) for linearized plasmids but failed to resolve circular forms.
• 2D charge vs. mass plots revealed distinct charge populations corresponding to different topologies, enabling structural discrimination not possible by length-based separation alone.
• Unexpected peaks (e.g., ~0.6 MDa in linearized samples and minor circRNA isoforms) indicated potential degradation or secondary structures detectable by CDMS.

Benefits and Practical Applications

• Enhanced mass accuracy and direct measurement support rigorous quality control of plasmid and mRNA in biomanufacturing.
• Ability to detect and quantify structural variants and degradation products aids in optimizing template preparation and in vitro transcription.
• Complementary use with capillary electrophoresis provides a more comprehensive analytical workflow for therapeutic mRNA production.

Future Trends and Applications

• Integration of CDMS into routine QC pipelines for gene therapy vector and mRNA vaccine development.
• Development of higher throughput ELIT-based instruments enabling real-time monitoring of macromolecular integrity.
• Expansion to analyze larger complexes, improved resolution of isoforms, and coupling with ion mobility for structural insights.

Conclusion

CDMS demonstrates superior capability in direct mass measurement and structural discrimination of DNA plasmids and mRNA. Its integration with existing techniques enhances analytical rigor in biopharmaceutical development, ensuring higher quality and consistency of therapeutic RNA products.